EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union
Crossref DOI link: https://doi.org/10.1186/1129-2377-15-S1-G24
Published Online: 2014-09-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matharu, M
Pascual, J
Remahl, I Nilsson
Odom, D
Gutierrez, L
Andrews, E
Largent, J
Johannes, C
License valid from 2014-09-18